Showing results (31-40 of 43) with videos related to
Sort By:
Pageof 5
The Annals of Thoracic Surgery|December 3, 2014
Postoperative atrial fibrillation impacts on costs and one-year clinical outcomes: the Veterans Affairs Randomized On/Off Bypass TrialG Hossein Almassi, Todd H Wagner, Brendan Carr, et al.The Annals of Thoracic Surgery|March 5, 2013
Changes in health-related quality of life in off-pump versus on-pump cardiac surgery: Veterans Affairs Randomized On/Off Bypass trialMuath Bishawi, A Laurie Shroyer, John S Rumsfeld, et al.The Annals of Thoracic Surgery|November 12, 2013
Effect of clopidogrel use post coronary artery bypass surgery on graft patencyRamin Ebrahimi, Faisal G Bakaeen, Abhimanyu Uberoi, et al.The Journal of Thoracic and Cardiovascular Surgery|December 24, 2019
New-onset postoperative atrial fibrillation impact on 5-year clinical outcomes and costsG Hossein Almassi, Robert B Hawkins, Muath Bishawi, et al.Journal of Cardiac Surgery|December 15, 2017
Concordance between administrative data and clinical review for mortality in the randomized on/off bypass follow-up study (ROOBY-FS)Jacquelyn A Quin, Brack Hattler, Annie Laurie W Shroyer, et al.Circulation. Cardiovascular Quality and Outcomes|April 20, 2019
Clinical and Angiographic Predictors of Patient-Reported Angina 1 Year After Coronary Artery Bypass Graft SurgeryBrack Hattler, Brendan M Carr, John Messenger, et al.The New England Journal of Medicine|August 17, 2017
Five-Year Outcomes after On-Pump and Off-Pump Coronary-Artery BypassA Laurie Shroyer, Brack Hattler, Todd H Wagner, et al.The American Journal of Cardiology|February 7, 2018
Comparison of Outcomes and Costs Associated With Aspirin ± Clopidogrel After Coronary Artery Bypass GraftingRamin Ebrahimi, Sandeep Gupta, Brendan M Carr, et al.The Journal of Thoracic and Cardiovascular Surgery|October 17, 2015
Resident versus attending surgeon graft patency and clinical outcomes in on- versus off-pump coronary artery bypass surgeryG Hossein Almassi, Brendan M Carr, Muath Bishawi, et al.The Journal of Antimicrobial Chemotherapy|September 28, 2005
Comparative in vitro antimicrobial activity of a novel quinolone, garenoxacin, against aerobic and anaerobic microbial isolates recovered from general, vascular, cardiothoracic and otolaryngologic surgical patientsCharles E Edmiston, Candace J Krepel, Karen S Kehl, et al.Pageof 5